NCCM
OSIR

Nine Chapters Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Nine Chapters Capital Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-31,800
Closed -$400K – 1379
2014
Q3 		$400K Buy
+31,800
New +$454K 0.04% 606

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nine Chapters Capital Management's OSIR Position: Q4 2014 in Review

Nine Chapters Capital Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2014, closing a stake of 31,800 shares — an estimated $400K sold.

Nine Chapters Capital Management first reported a position in OSIR in Q3 2014 and held it in 1 quarter. The position peaked at $400K in Q3 2014. 66 funds tracked by Wall St. Rank hold OSIR as of Q4 2014.

  • Nine Chapters Capital Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Nine Chapters Capital Management sold 31,800 Osiris Therapeutics, Inc. Common Stock shares in Q4 2014, an estimated $400K.
  • Nine Chapters Capital Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2014 and held it in 1 quarter.
  • Nine Chapters Capital Management's Osiris Therapeutics, Inc. Common Stock position peaked at $400K in Q3 2014.
  • 66 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2014.

Based on Nine Chapters Capital Management's 13F filing for Q4 2014, filed 9 Feb 2015.